WallStreetZenWallStreetZen

NASDAQ: IPA
Immunoprecise Antibodies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Immunoprecise Antibodies revenue was $17.90M for the trailing 12 months ending Apr 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Apr 30, 2025 was $5.1M, up 18.4% from last quarter. For the last reported fiscal year 2025 ending Apr 30, 2025, IPA annual revenue was $17.8M, with 0% growth year-over-year.

IPA past revenue growth

How has IPA's revenue growth performed historically?

Company
0.01%
Industry
1,675.38%
Market
37.92%
IPA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IPA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IPA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IPA revenue history

Current Revenue
$17.8M
Current Earnings
-$21.9M
Current Profit Margin
-123.3%

Be the first to know when IPA announces revenue.

IPA Revenue History By Year

IPA Yearly RevenueIPA RevenueIPA ChangeIPA Revenue Growth
2025-04-30$17.77M$1.45k+0.01%
2024-04-30$17.77M$2.35M+15.21%
2023-04-30$15.42M$53.39k+0.35%
2022-04-30$15.37M$805.65k+5.53%
2021-04-30$14.56M$4.59M+46.06%
2020-04-30$9.97M$1.85M+22.73%
2019-04-30$8.12MN/AN/A

1 of 1

Immunoprecise Antibodies Revenue FAQ

What was IPA's revenue last quarter?

On Invalid Date, Immunoprecise Antibodies (NASDAQ: IPA) reported Q1 2025 revenue of $5.06 million up 8.08% year over year. In the same quarter last year, Immunoprecise Antibodies's revenue was $4.68 million.

What was Immunoprecise Antibodies's revenue in 2025?

Immunoprecise Antibodies's annual revenue for the twelve months ending Apr 30, 2025 was $17.77 million, a 0.01% increase year over year.

How much does Immunoprecise Antibodies make in a day?

Based on Immunoprecise Antibodies annual revenue for the past five years, IPA makes an average of $44,321.80 per day.

What was Immunoprecise Antibodies's annual revenue growth in the past year?

As of Q3 2025, Immunoprecise Antibodies's revenue has grown 0.01% year over year. This is 1,675.37 percentage points lower than the US Biotechnology industry revenue growth rate of 1,675.38%. Immunoprecise Antibodies's revenue in the past year totaled $17.90 million.

How much does Immunoprecise Antibodies make in a year?

Immunoprecise Antibodies's revenue by year for the past five years is:
  • Immunoprecise Antibodies's revenue for the twelve months ending Apr 30, 2025 was $17.77 million, a 0.01% increase year over year.
  • Immunoprecise Antibodies's annual revenue for Apr 30, 2024 was $17.77 million, a 15.21% increase from 2023.
  • Immunoprecise Antibodies's annual revenue for 2023 was $15.42 million, a 0.35% increase from 2022.
  • Immunoprecise Antibodies's annual revenue for 2022 was $15.37 million, a 5.53% increase from 2021.
  • Immunoprecise Antibodies's annual revenue for 2021 was $14.56 million, a 46.06% increase from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.